Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 88: 102-108, 2000;
8750-7587/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fedele, M. J.
Right arrow Articles by Farrell, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fedele, M. J.
Right arrow Articles by Farrell, P. A.
Vol. 88, Issue 1, 102-108, January 2000

Severe diabetes prohibits elevations in muscle protein synthesis after acute resistance exercise in rats

Mark J. Fedele, Jazmir M. Hernandez, Charles H. Lang, Thomas C. Vary, Scot R. Kimball, Leonard S. Jefferson, and Peter A. Farrell

Noll Physiological Research Center and Department of Kinesiology, Pennsylvania State University, University Park 16802; and Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

This study determined whether rates of protein synthesis increase after acute resistance exercise in skeletal muscle from severely diabetic rats. Previous studies consistently show that postexercise rates of protein synthesis are elevated in nondiabetic and moderately diabetic rats. Severely diabetic rats performed acute resistance exercise (n = 8) or remained sedentary (n = 8). A group of nondiabetic age-matched rats served as controls (n = 9). Rates of protein synthesis were measured 16 h after exercise. Plasma glucose concentrations were >500 mg/dl in the diabetic rats. Rates of protein synthesis (nmol phenylalanine incorporated · g muscle-1 · h-1, means ± SE) were not different between exercised (117 ± 7) and sedentary (106 ± 9) diabetic rats but were significantly (P < 0.05) lower than in sedentary nondiabetic rats (162 ± 9) and in exercised nondiabetic rats (197 ± 7). Circulating insulin concentrations were 442 ± 65 pM in nondiabetic rats and 53 ± 11 and 72 ± 19 pM in sedentary and exercised diabetic rats, respectively. Plasma insulin-like growth factor I concentrations were reduced by 33% in diabetic rats compared with nondiabetic rats, and there was no difference between exercised and sedentary diabetic rats. Muscle insulin-like growth factor I was not affected by resistance exercise in diabetic rats. The results show that there is a critical concentration of insulin below which rates of protein synthesis begin to decline in vivo. In contrast to previous studies using less diabetic rats, severely diabetic rats cannot increase rates of protein synthesis after acute resistance exercise.

hypoinsulinemia; anabolic factors; stress


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

REGULATION OF PROTEIN synthesis by insulin can be viewed in the context of the amount of insulin available and the stimulus for altered rates of protein synthesis. Severe hypoinsulinemia lasting several days clearly reduces protein synthesis in many tissues, including skeletal muscle (19, 31, 32, 46). This reduction in protein synthesis in skeletal muscle is mechanistically linked to a block in peptide chain initiation (35, 36). In contrast, Garlick et al. (24) demonstrated that low doses of insulin infused into rats for 1 h caused hypoglycemia but had little effect on rates of protein synthesis in skeletal muscle. Rates of protein synthesis only became elevated at very high infusion rates of insulin. Reducing insulin below basal concentrations did not alter protein synthesis; however, this infusion lasted only 1 h, and Jefferson et al. (32) demonstrated a perfusion-induced block in peptide chain initiation and protein synthesis when an insulin-free perfusate is infused for 2 h. Thus the duration of hypoinsulinemia is an important factor for the regulation of protein synthesis.

Using an in situ bilateral hindlimb perfusion, Fluckey et al. (22) demonstrated that postexercise elevations in rates of protein synthesis were ablated when insulin was omitted from the perfusion medium. That study also verified (4) that elevating insulin concentrations for a short period of time (30 min) in nonstressed animals did not increase protein synthesis. It is possible that a low but critical concentration of insulin must be available for anabolism to occur after exercise. One of our objectives for this study was to determine whether such a critical concentration exists in vivo.

Recent studies demonstrate that rates of protein synthesis are higher after acute moderate-intensity resistance exercise in moderately diabetic rats (17, 18). Whether severely diabetic rats can increase rates of protein synthesis after endurance or resistance exercise has not been investigated. The studies reported here investigated whether severe hypoinsulinemia, in combination with other factors known to alter protein turnover, was associated with an inability to increase protein synthesis after acute moderate-intensity resistance exercise.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

All experimental procedures were approved by the Institutional Animal Care and Use Committee of the Pennsylvania State University. Male Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN) were used in all experiments; they were housed in temperature- and humidity-controlled holding facilities with lights on at 0700 and off at 1900. Rats were fed ad libitum a standard rodent diet (diet 5001, PMI Feeds), which contained 24% protein, 12% fat, 50% carbohydrate, 7% ash, 6% fiber, and vitamins.

Partial pancreatectomy. On the basis of previous work (15), a partial pancreatectomy procedure was used, and the procedure was modified to include rats that weighed 110-140 g as opposed to the weights (90-110 g) suggested by Foglia (23). We find that a larger percentage (congruent 80%) of the animals become diabetic when heavier rats are pancreatectomized. We also used a microcauterizer to eliminate small pancreatic blood vessels and to reduce bleeding during surgery. Sterile conditions were maintained throughout the surgery. Rats were anesthetized using methyoxyflurane and were kept on a heated surgical pad. The procedure requires the physical removal of pancreatic tissue from the splenic, duodenal, and pyloric regions while major blood vessels are left intact. This is accomplished using sterile cotton Q-tips. Pancreatic tissue between the bile duct and the duodenum is not removed, since this approximates 10% of the original total pancreatic tissue. In an effort to produce severely diabetic rats, we were fastidious in removing as much pancreatic tissue as possible. At the conclusion of surgery, rats were given ampicillin (5 mg/100 g body wt sc; Sigma Chemical, St. Louis, MO) as an antimicrobial agent. Two weeks after partial pancreatectomy, a tail vein blood sample was obtained in the fed state to determine plasma glucose concentrations with use of a Beckman Glucose Analyzer 2. Rats that were not severely diabetic (<475 mg/dl) were eliminated from the study. Sixteen diabetic rats were randomly assigned to exercise (n = 8) or sedentary (n = 8) groups. Age-matched nondiabetic sedentary (n = 15) and exercised (n = 6) control rats were housed and handled in a manner that was identical to that used for diabetic rats, with the exception of surgery and tail vein sampling to verify diabetic status. We previously used sham-operated rats for nondiabetic controls, and there was no difference in rates of protein synthesis or plasma insulin levels between the sham and nonsham controls (17). Therefore, we have subsequently used rats with no surgical manipulation for nondiabetic controls.

Resistance exercise. Details of the exercise protocol have been described previously (20). Briefly, rats were operantly conditioned to touch an illuminated bar low on a Plexiglas exercise cage and then were taught to stand and touch an illuminated bar that was located high on the opposite wall of the cage. Electrical foot shock (<2 mA, 60 Hz) was used to reinforce these movements. Once the learning process was completed (3-4 sessions), weighted vests were strapped over the scapulae, and the rats were required to touch the high bar 50 times during one acute exercise session. We defined acute resistance exercise as four separate sessions with 1 day of rest between sessions. The rats performed 50 repetitions each day with 0.2 (day 1), 0.4 (days 2 and 3), and 0.6 (day 4) g weighted vest/g body wt. Previous work showed that a rat that was naive to the lifting procedure would not lift the 0.6 g/g body wt on the 1st day weights were applied to the vest. This protocol can be considered acute, because it does not result in changes in muscle weight (21). We recognize that some metabolic adaptations may occur as a result of multiple bouts of acute exercise (29). However, the rats in this study were clearly not "trained." Exercise sessions occurred in the dark (red light) in the late afternoon. Rats that did not perform exercise (sedentary) were placed in the lifting cages at least three times during the week of acute exercise and were given five electric shocks to simulate some of the stress experienced by the exercised groups. One of these shock control sessions occurred 16 h before the determination of rates of protein synthesis.

Rates of protein synthesis. All measurements of rates of protein synthesis occurred 16 h after the last bout of acute resistance exercise. Food was withdrawn from the rats during the last 5 h of this 16-h period. Rats were anesthetized with methoxyflurane, and the left carotid artery and right jugular vein were cannulated. Rats remained unconscious after the placement of catheters and during the measurement of rates of protein synthesis. Total time between the onset of anesthesia and completion of surgery was 10-15 min. One milliliter of arterial blood was taken to determine plasma concentrations of insulin, insulin-like growth factor (IGF) I, corticosterone, free fatty acids, and glucose. A flooding dose (26) of L-[2,3,4,5,6-3H]phenylalanine (1 mCi/rat; Amersham Life Science, Arlington Heights, IL) in unlabeled phenylalanine (150 mM; 1 ml/100 g body wt total volume) was injected immediately after cannulation into the venous catheter over a 15-s period. Arterial blood (1 ml) was taken at 6 and 10 min, and then the gastrocnemius muscle was excised. The superficial white muscle was removed, and the remaining muscle was immediately frozen in liquid nitrogen. Fiber type analysis (data not shown) of this portion of the gastrocnemius suggests that it is most like the "mixed" portion of the gastrocnemius, as described by Armstrong and Phelps (2). Frozen muscles were stored at -70°C until phenylalanine incorporation into TCA-precipitable protein was analyzed using dabsylation of the amino acid and measurement on an HPLC (12). Radioactivity in the phenylalanine peak was measured by liquid scintillation counting with appropriate correction for quench. Protein determinations were made using the biuret method, and rates of muscle protein synthesis were calculated using the method of Garlick et al. (26). Hematocrit and Hb were measured using standard techniques.

Comparison to previous studies. Data were collected in this study for severely diabetic and nondiabetic rats only. In combination with the present data, we used our previously published work on nondiabetic (16-18, 21, 22) and moderately diabetic (17) rats to investigate a possible in vivo relationship between arterial plasma insulin concentrations and rates of protein synthesis. Animal handling, surgery, and experimental timing were identical for all animals used in the data provided in Fig. 3. The data set included exercised and sedentary rats.

Hormone, binding proteins, and free fatty acid assays. Plasma insulin (43) and corticosterone (1) concentrations were determined by RIA. The antibody (no. 1013, Linco Research, St. Charles, MO) used in the rat insulin assay also recognizes other mammalian insulin isoforms but does not cross-react with glucagon, pancreatic polypeptide, somatostatin, or IGF-I. The corticosterone antibody (no. RPA 548, Amersham Life Science) does not cross-react with other steroids (<3%). Corticosterone is first separated from corticosterone-binding globulin by heating, which then allows for its direct measurement (1). Plasma IGF-I was determined by RIA with a modified acid-ethanol (0.25 N HCl-87.5% ethanol) procedure with cryoprecipitation (14, 39). The IGF-I antibody (lot no. AFP4892898, National Hormone and Pituitary Program) does not cross-react with insulin or IGF-II and has a sensitivity of 0.03 ± 0.08 ng/tube, and the intra-assay coefficient of variation is <5%. Gastrocnemius muscles used for IGF-I determinations were extracted using acid homogenization and Sep-Pak C18 extraction (14, 39) and then assayed using RIA.

IGF binding protein (IGFBP)-3 in plasma was determined by Western ligand blot analysis, as described by Hossenloop et al. (30) and slightly modified by our laboratory (52). Samples were separated on a 15% (wt/vol) SDS-polyacrylamide gel without reduction of disulfide bonds. The electrophoresed proteins were transferred onto nitrocellulose in Tris-methanol-glycine buffer. Nitrocellulose sheets were washed and then incubated overnight with radiolabeled IGF-I. The nitrocellulose sheets were washed extensively in Tween 20, dried, and autoradiographed with X-ray film (Kodak X-Omat AR, Eastman Kodak, Rochester, NY) and intensifying screens (DuPont, Wilmington, DE) at -70°C for 2-4 days. Plasma IGFBP-1 was determined by Western blot analysis. Briefly, plasma samples were separated on a 12.5% (wt/vol) SDS-polyacrylamide gel under nonreducing conditions, as previously described (38). Separated proteins were electroblotted onto nitrocellulose and blocked for 2 h at room temperature with Tris-buffered saline containing 1% nonfat dry milk. The membranes were then incubated with a 1:2,000 dilution of antiserum against rat IGFBP-1 at room temperature for 2 h. Antigen-antibody complexes were identified with goat anti-rabbit IgG conjugated with horseradish peroxidase (Sigma Chemical) and exposed to the enhanced chemiluminescence detection system (Amersham) for 1 min and to X-ray film for 10-30 s. Bands were scanned (Microtek ScanMaker IV) and quantitated using NIH Image 1.6 software. Representative samples from all experimental groups were electrophoresed on the same gel.

Nonesterified free fatty acids were determined enzymatically (NEFA-C kit, Wako Chemicals, Richmond, VA). This method is based on the acylation of CoA by the fatty acids in the presence of acyl-CoA synthase. The acyl-CoA produced is oxidized by acyl-CoA oxidase with the generation of hydrogen peroxide. The hydrogen peroxide in the presence of peroxidase permits the condensation of 3-methyl-N-ethyl- (beta -hydroxyethyl)-aniline with 4-aminoantipyrine to form a colored compound, which is measured colorimetrically at 550 nm (13).

Statistical analysis. Statistical differences among groups were assessed using ANOVA. When significant F ratios were present, a Student-Newman-Keuls post hoc procedure was used to evaluate differences among means. A 0.05 level of confidence was chosen a priori. The number of rats in each group is indicated. Values are means ± SE.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Table 1 provides characteristics of the rats used in the study. Plasma glucose concentrations were similar between diabetic groups: range 507-608 and 508-600 mg/dl in exercised and sedentary rats, respectively. Nondiabetic rats had lower plasma glucose concentrations and greater body weights than the diabetic groups, but similar Hb and hematocrit values were found among all the groups. There were no significant differences in plasma corticosterone concentrations between the groups. Exercise, 16 h before assessment, did not change levels of plasma free fatty acids in nondiabetic or diabetic rats. However, free fatty acid levels were higher in diabetic than in nondiabetic rats (P < 0.05).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Physical and physiological characteristics of rats

Figure 1 provides rates of protein synthesis for the various groups. No significant difference was found between rates of protein synthesis for sedentary and acutely exercised diabetic rats, and rates for both groups were significantly (P < 0.05) lower than for nondiabetic groups. Rates of protein synthesis were higher in exercised nondiabetic rats than in sedentary rats. Figure 2 provides arterial plasma insulin concentrations at the time rates of protein synthesis were measured. Prior exercise did not alter insulin concentrations in diabetic or nondiabetic rats. Group means were markedly lower for severely diabetic than for nondiabetic rats.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 1.   Rates of protein synthesis for nondiabetic sedentary rats and severely diabetic rats that exercised or remained sedentary. Values are means ± SE. * Values for nondiabetic rats are significantly higher (P < 0.05) than for diabetic groups, which did not differ from each other [not significant (ns)]. **Values for nondiabetic exercised rats are significantly higher (P < 0.05) than for nondiabetic sedentary rats.



View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Arterial plasma insulin concentrations for nondiabetic sedentary rats and severely diabetic rats that exercised or remained sedentary. Values are means ± SE. * Concentrations for nondiabetic rats were significantly (P < 0.05) higher than for diabetic groups, which did not differ each other (ns = not significant).

Plasma IGF-I (Table 2) concentrations in severely diabetic groups were not different between exercised and sedentary rats but were significantly lower than in nondiabetic controls (P < 0.05). Muscle IGF-I (Table 2) was higher in the exercised severely diabetic than in sedentary rats (3.65 ± 0.7 vs. 2.32 ± 0.6 ng IGF-I/g muscle); however, this difference was not statistically significant (P = 0.1).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Arterial plasma concentrations of IGF-I, IGFBPs, and muscle concentrations of IGF-I for groups of rats

The large majority of IGF-I in the circulation is carried bound to one of at least six different high-affinity binding proteins. In the present study we determined the plasma concentration of two of these IGFBPs, IGFBP-1 and IGFBP-3. Diabetic rats had an ~10-fold elevation in the concentration of IGFBP-1 compared with nondiabetic rats (Table 2). Moreover, there was no detectable effect of exercise on nondiabetic or diabetic rats compared with their respective sedentary controls. In contrast, diabetic rats had a >50% decrease in the circulating concentration of IGFBP-3 compared with nondiabetic rats (Table 2). Again, there did not appear to be any significant effect of exercise on plasma IGFBP-3 levels in either group of animals.

Figure 3 provides data on 97 rats from the present and previous studies (16-18, 21, 22). Data are from previous publications and included rats that were moderately diabetic (n = 29), severely diabetic (n = 19), and nondiabetic (n = 49). For clarity of presentation, no distinction was made between exercised and sedentary rats, since several (18, 22) previous studies have shown that acute exercise does not alter arterial plasma insulin concentrations in nondiabetic rats. In one study, however, we observed lower plasma insulin concentrations in exercised than in sedentary moderately diabetic rats (17). Over a wide range (congruent 80-600 pM) of insulin concentrations, there was no association between insulin concentrations and rates of protein synthesis. However, rates of protein synthesis were reduced when circulating insulin fell below ~80 pM. This value was determined as the intersection of two linear regression lines based on plasma insulin concentrations >120 pM (with the associated rates of protein synthesis) or <100 pM.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Relationship between arterial plasma insulin and rates of protein synthesis for 97 rats. Data from present study and from previous studies are shown (16-18, 21, 22). All insulin samples were obtained from 5-h fasted rats immediately before determination of rates of protein synthesis. , Nondiabetic rats; black-triangle, moderately diabetic rats; , severely diabetic rats.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Elevations in rates of protein synthesis are consistently observed using not only our model (16-18, 21, 22) but also other models of resistance exercise (7, 8, 53, 54). The most important finding in this study is that rates of protein synthesis are not elevated after acute resistance exercise in severely diabetic rats. This lack of effect is in contrast to significant elevations in moderately diabetic rats after similar exercise (18). The model of resistance exercise used in the present study increases rates of protein synthesis 26-93% (16, 21, 22) in nondiabetic rats and 17-38% (9) in moderately diabetic rats. In the latter rats, 5-h fasted plasma glucose concentrations were 320-410 mg/dl and circulating insulin concentrations were about twice (17) those observed in the severely diabetic rats used in this study. The markedly reduced insulin concentrations in the present study may partially explain why an expected increase in rates of protein synthesis did not occur after exercise.

The amount of insulin required for normal anabolic responses after acute exercise is difficult to establish. The timing of the measurement of protein synthesis after exercise is also an important consideration, since shortly after (1 h) intense treadmill exercise, insulin does not augment exercise-induced changes in protein synthesis (3, 27). Data in Fig. 3 support those findings, but only from the perspective of high or elevated circulating insulin. When insulin drops below a critical concentration (congruent 80 pM in a 5-h fasted state), the inhibitory effect of hypoinsulinemia on the ability to maintain or increase rates of protein synthesis is marked. The finding that a low critical concentration of insulin is needed for an anabolic response after a stress is not incompatible with numerous studies in humans and rats showing that acute hyperinsulinemia does not elevate protein synthesis when the organism is in a quiescent state (4, 28, 45, 58). Thus, above the critical concentration found in the present study, insulin is probably permissive, rather than regulatory, for protein synthesis.

The flooding-dose technique and the constant-infusion method, the two methods commonly employed to measure in vivo rates of protein synthesis, require assumptions and have potential limitations. The strengths and weaknesses of these two techniques have been reviewed (25, 48). Although these techniques typically provide reasonable agreement, discrepancies between them can exist. Davis et al. (11) showed in neonatal pigs that, 30 min after a flooding dose of phenylalanine as the radiolabeled precursor, there is an equilibrium of the phenylalanine-specific radioactivity between blood, phenylalanyl-tRNA precursor pool, and skeletal muscle tissue. Thus blood phenylalanine-specific radioactivity during the flooding-dose technique is an accurate estimate of the precursor pool of phenylalanyl-tRNA in skeletal muscle. This recent study supports the validity of using a flooding dose of phenylalanine to measure in vivo rates of protein synthesis in skeletal muscle. Although we acknowledge its potential limitations, we (16-18, 21, 22, 51) and many others (33, 42) have used the flooding-dose technique extensively to study changes in rates of protein synthesis in rats as a result of various perturbations.

The rats used in these studies were mature yet still growing. There are differences in insulin-mediated protein synthesis between mature and growing animals. Davis and co-workers (10, 55) showed that there is a curvilinear relationship between plasma insulin and skeletal muscle rates of protein synthesis in neonatal pigs and that this response declines with development. Studies in humans and rats demonstrate that protein synthesis in response to insulin is attenuated with aging. It is important to note that these studies were performed in nonstressed conditions. However, Fluckey et al. (21) showed that, with the addition of a resistance exercise stimulus, skeletal muscle protein synthesis remains insulin sensitive in old rats. The availability of insulin and its effects on skeletal muscle protein metabolism are thus relevant to young and old populations.

In addition to insulin, many other factors, including IGF-I, growth hormone, anabolic steroids, corticosterone, nutritional status, and amino acid availability, contribute to protein stability (34, 47, 50). We previously showed that food intake is not affected by the exercise model used in this study (21, 22). Yan et al. (56) reported that IGF-I immunoreactivity in tibialis anterior muscle increased at 4 days after eccentric exercise but not before this time in nondiabetic rats. Our previous work (18) supports this finding, since we found no significant change in muscle IGF-I 16 h after exercise in nondiabetic rats. These previous data were the reason we did not measure muscle IGF-I in nondiabetic rats in this study (Table 2). However, muscle IGF-I was significantly elevated in moderately diabetic rats in the previous study, suggesting that intramuscular IGF-I may play a compensatory role to facilitate an appropriate anabolic response after resistance exercise in moderately hypoinsulinemic rats (18). Unlike mildly diabetic rats, data in Table 2 demonstrate that muscle IGF-I in severely diabetic rats was not significantly different as a result of exercise. Thus severe diabetes may hinder a compensatory role by muscle IGF-I under these conditions.

Although it is accepted that circulating levels of IGF-I are a reflection of growth hormone-mediated production by the liver, the regulation of nonhepatic IGF-I expression is less clear. In addition to acting in a classical endocrine manner, IGF-I is thought to have paracrine and autocrine functions as well. This is illustrated by the finding that in mice a significant increase in muscle IGF-I is not paralleled by a concomitant increase in plasma IGF-I (9). Regulation of IGF-I production is influenced by such regulators as hormonal levels, nutritional status, and numerous mitogenic and myogenic factors. Differential expression of the IGF-I gene as a result of alternative splicing or multiple transcription start sites allows for the tissue-specific regulation of IGF-I (49). Yang et al. (57) showed in skeletal muscle that there is a specific IGF-I transcript that is expressed after mechanical stretching. This could explain our finding of elevated intramuscular IGF-I in moderately diabetic rats after resistance exercise (18). However, neither nondiabetic nor severely diabetic rats exhibited this same effect. The reason for this is unclear, but perhaps insulin is performing a functional role in regulating muscle IGF-I production. This failure to increase muscle IGF-I, in addition to hypoinsulinemia, may be partially responsible for the inability of the severely diabetic rats to increase rates of protein synthesis after resistance exercise.

A pattern similar to that for muscle IGF-I existed for plasma IGF-I. The concentration of this factor increased with exercise in moderately diabetic rats (18); however, a diabetes-induced reduction in the circulating concentrations of this factor (50) was not overcome by exercise. In the present study, severely diabetic rats had very low plasma IGF-I concentrations, which were not changed by exercise. One interpretation of these results is that an anabolic response to resistance exercise is not possible when plasma IGF-I, insulin, and muscle IGF-I concentrations are extremely low.

The bioavailability and bioactivity of IGF-I can be influenced by the prevailing concentration of IGFBPs (40). In the present study we examined the influence of diabetes and/or exercise on the relative concentration of two important IGFBPs. First, IGFBP-3 was assessed, because it carries the large majority (>80%) of IGF-I in the blood. Our results demonstrate a >50% reduction in plasma IGFBP-3 in sedentary diabetic rats compared with sedentary nondiabetic rats. This diabetes-induced decrease in IGFBP-3 has been previously reported (5). Furthermore, there was no effect of exercise in either group of animals. Previous studies have indicated that various types of exercise result in an increase (37) or no change (44) in plasma IGFBP-3 levels. Differences in the type, duration, and/or intensity of exercise between these studies may explain differences in the IGFBP-3 response to various exercise stimuli. A smaller amount of IGF-I in the blood is also bound to IGFBP-1, which is a lower-molecular-weight binding protein thought to be responsible for the acute regulation of IGF-I bioavailability (40). As previously described by others (6), IGFBP-1 is markedly elevated by diabetes. This increase appears to be at least partly due to the severe hypoinsulinemia present in this condition (6). Again, however, there was no detectable effect of exercise on IGFBP-1. This lack of an exercise-induced change in IGFBP-1 is consistent with some studies (37) but differs from others, which demonstrate mild elevations (44) after exercise. As with IGFBP-3, the exact type, duration, and intensity of the exercise stimuli necessary to produce changes in one or more of the IGFBPs are unclear.

It is also important to note that most of the previous studies that demonstrate an effect on rates of protein of normalizing insulin from low to normal concentrations (19, 35, 41, 42, 46) have manipulated insulinemia for very short periods (hours or days). Rats in the present study were diabetic for >= 5 wk, and this prolonged hypoinsulinemia may alter the effectiveness of insulin for stimulating anabolism and have other adverse metabolic perturbations. Although a growth curve was not provided for the rats in this study, we previously showed that rats that are moderately diabetic for >10 wk still grow, albeit at a slightly reduced rate compared with nondiabetic rats (16). Likewise, the rats continue to grow during the 7-day period of weight lifting. Additional studies are needed to determine the importance of duration of diabetes on anabolic responses after exercise.

Summary. In contrast to nondiabetic and moderately diabetic rats, severely diabetic rats cannot elevate rates of protein synthesis after acute resistance exercise. Above a certain concentration of circulating insulin (congruent 80 pM in a 5-h fasted state), rates of protein synthesis are not associated with circulating insulin, even when those insulin concentrations are too low to maintain normal glycemia. In moderate but not severe diabetes, other regulators of protein synthesis, such as muscle IGF-I, are able to compensate for the hypoinsulinemia (or other untested factors) to allow appropriate anabolic responses. The results of this study suggest that there is a critical concentration threshold for insulin below which anabolic responses are negated. Future studies need to determine whether a minimum level of circulating insulin alone is sufficient to ablate anabolic responses or whether marked hypoinsulinemia must be coupled with reduced circulating or muscle IGF-I or other factors for this deficit to occur.


    ACKNOWLEDGEMENTS

We thank Marlin Druckenmiller, Fred Weyandt, Jaycee Kostyak, Leelakrishna Nallamshetty, Mathew Osborne, Doug Johnson, Jen West, Mike Abraham, and John Miller for superb technical efforts. We also thank Dr. A. F. Parlow (National Institute of Diabetes and Digestive Kidney Diseases, National Hormone and Pituitary Program) for the generous gift of the IGF-I antibody and Dr. S. Shimisaki (Scripps Research Institute, La Jolla, CA) for the IGFBP antiserum.


    FOOTNOTES

These studies were supported by National Institutes of Health Grants AR-43127 (P. A. Farrell), GM-39277 (T. C. Vary), and DK-15658 (L. S. Jefferson).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: P. A. Farrell, Noll Physiological Research Center, Pennsylvania State University, University Park, PA 16802 (E-mail: paf4{at}psu.edu).

Received 17 March 1999; accepted in final form 14 September 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Al-Dujaili, E. A. S., B. C. Williams, and C. R. W. Edwards. The development and application of a direct radioimmunoassay for corticosterone. Steroids 37: 157-176, 1981[Medline].

2.   Armstrong, R. B., and R. O. Phelps. Muscle fiber type composition of the rat hindlimb. Am. J. Anat. 171: 259-272, 1984[ISI][Medline].

3.   Balon, T. W., A. Zorzano, J. L. Treadway, M. N. Goodman, and N. B. Ruderman. Effect of insulin on protein synthesis and degradation in skeletal muscle after exercise. Am. J. Physiol. Endocrinol. Metab. 258: E92-E97, 1990[Abstract/Free Full Text].

4.   Bennet, W. M., A. A. Connacher, K. Smith, R. T. Jung, and M. J. Rennie. Inability to stimulate skeletal muscle or whole body protein synthesis in type 1 (insulin dependent) diabetic patients by insulin-plus-glucose during amino acid infusion: studies of incorporation and turnover of trace L-[1-13C]leucine. Diabetologia 33: 43-51, 1990[ISI][Medline].

5.   Bereket, A., C. H. Lang, S. L. Blethen, J. Fan, R. A. Frost, and T. A. Wilson. Insulin-like growth factor binding protein (IGFBP)-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J. Clin. Endocrinol. Metab. 80: 2282-2288, 1995[Abstract].

6.   Bereket, A., C. H. Lang, S. L. Blethen, M. C. Gelato, J. Fan, R. A. Frost, and T. A. Wilson. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 80: 1312-1317, 1995[Abstract].

7.   Biolo, G., S. P. Maggi, B. D. Williams, K. D. Tipton, and R. E. Wolfe. Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans. Am. J. Physiol. Endocrinol. Metab. 268: E514-E520, 1995[Abstract/Free Full Text].

8.   Booth, F., and D. B. Thomason. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol. Rev. 71: 541-584, 1991[Free Full Text].

9.   Coleman, M. E., F. DeMayo, K. C. Yin, H. M. Lee, and R. Geske. Myogenic vector expression of insulin like growth factor-I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem 270: 12109-12116, 1995[Abstract/Free Full Text].

10.   Davis, T. A., D. G. Burrin, M. L. Fiorotto, P. J. Reeds, and F. Jahoor. Roles of insulin and amino acids in the regulation of protein synthesis in the neonate. J. Nutr. 128: 347S-350S, 1998.

11.   Davis, T. A., M. L. Fiorotto, H. V. Nguyen, and D. G. Burrin. Aminoacyl-tRNA and tissue free amino acid pools are equilibrated after a flooding dose of phenylalanine. Am. J. Physiol. Endocrinol. Metab. 277: E103-E109, 1999[Abstract/Free Full Text].

12.   Drenevich, D., and T. C. Vary. Analysis of physiological amino acids using dabsyl derivatization and reversed-phase liquid chromatography. J. Chromatogr. 613: 137-144, 1993[ISI][Medline].

13.   Elphick, M. C. Modified colorimetric ultramicro method for estimating NEFA in serum. J. Clin. Pathol. 21: 567-570, 1968[Abstract/Free Full Text].

14.   Fan, J., P. E. Molina, M. C. Gelato, and C. H. Lang. Differential tissue regulation of insulin-like growth factor-1 content and binding proteins after endotoxin. Endocrinology 134: 1682-1692, 1994.

15.   Farrell, P. A., A. L. Caston, and D. Rodd. Changes in insulin response to glucose after exercise training in partially pancreactectomized rats. J. Appl. Physiol. 70: 1563-1569, 1991[Abstract/Free Full Text].

16.   Farrell, P. A., M. J. Fedele, J. Hernandez, J. D. Fluckey, J. L. Miller III, C. H. Lang, T. C. Vary, S. R. Kimball, and L. S. Jefferson. Hypertrophy of skeletal muscle in diabetic rats in response to chronic resistance exercise. J. Appl. Physiol. 87: 1075-1082, 1999[Abstract/Free Full Text].

17.   Farrell, P. A., M. J. Fedele, T. C. Vary, S. R. Kimball, and L. S. Jefferson. Effects of intensity of acute resistance exercise on rates of protein synthesis in diabetic rats. J. Appl. Physiol. 85: 2291-2297, 1998[Abstract/Free Full Text].

18.   Farrell, P. A., M. J. Fedele, T. C. Vary, S. R. Kimball, C. H. Lang, and L. S. Jefferson. Regulation of protein synthesis after acute resistance exercise in diabetic rats. Am. J. Physiol. Endocrinol. Metab. 276: E721-E727, 1999[Abstract/Free Full Text].

19.   Flaim, K. E., M. E. Copenhaver, and L. S. Jefferson. Effects of diabetes on protein synthesis in fast- and slow-twitch rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 239: E88-E95, 1980[Abstract/Free Full Text].

20.   Fluckey, J. D., W. J. Kraemer, and P. A. Farrell. Pancreatic islet insulin secretion is increased after resistance exercise in rats. J. Appl. Physiol. 79: 1100-1105, 1995[Abstract/Free Full Text].

21.   Fluckey, J. D., T. C. Vary, L. S. Jefferson, W. J. Evans, and P. A. Farrell. Insulin stimulation of protein synthesis in rat skeletal muscle following resistance exercise is maintained with advancing age. J. Gerontol. A Biol. Sci. 51: B323-B330, 1996.

22.   Fluckey, J. D., T. C. Vary, L. S. Jefferson, and P. A. Farrell. Augmented insulin action on rates of protein synthesis after resistance exercise in rats. Am. J. Physiol. Endocrinol. Metab. 270: E313-E319, 1996[Abstract/Free Full Text].

23.   Foglia, V. A. Caracteristicas del la diabetes en la rata. Rev. Soc. Argentina Biol. 20: 21-37, 1944.

24.   Garlick, P. J., M. Fern, and V. R. Preedy. The effect of insulin infusion and food intake on muscle protein synthesis in postabsorptive rats. Biochem. J. 210: 669-676, 1983[ISI][Medline].

25.   Garlick, P. J., M. A. McNurlan, P. Essén, and J. Wernerman. Measurement of tissue protein synthesis rates in vivo: a critical analysis of contrasting methods. Am. J. Physiol. Endocrinol. Metab. 266: E287-E297, 1994[Abstract/Free Full Text].

26.   Garlick, P. J., M. A. McNurlan, and V. R. Preddy. A rapid and convenient technique for measuring the rate of protein synthesis in tissues by injection of [3H]phenylalanine. Biochem. J. 192: 719-723, 1980[ISI][Medline].

27.   Gautsch, T. A., J. C. Anthony, S. R. Kimball, G. L. Paul, D. K. Layman, and L. S. Jefferson. Availability of eIF4E regulates skeletal muscle protein synthesis during recovery from exercise. Am. J. Physiol. Cell Physiol. 274: C409-C414, 1998.

28.   Gelfand, R., and E. J. Barrett. Effect of physiological hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J. Clin. Invest. 80: 1-6, 1987.

29.   Green, H. J., M. Ball-Burnett, S. Symon, S. Grant, and G. Jamieson. Short-term training, muscle glycogen, and cycle endurance. Can. J. Appl. Physiol. 20: 315-324, 1995[Medline].

30.   Hossenloop, P., D. Seurin, B. Segonia-Quinson, S. Hardouin, and M. Binoux. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding sites. Anal. Biochem. 154: 138-143, 1986[ISI][Medline].

31.   Jefferson, L. S. Role of insulin in the regulation of protein synthesis. Diabetes 29: 487-496, 1980[ISI][Medline].

32.   Jefferson, L. S., D. E. Rannels, B. L. Munger, and H. E. Morgan. Insulin in the regulation of protein turnover in heart and skeletal muscle. Federation Proc. 33: 1098-1104, 1974[ISI][Medline].

33.   Jepson, M. M., J. M. Pell, P. C. Bates, and D. J. Millward. The effects of endotoxaemia on protein metabolism in skeletal muscle and liver of fed and fasted rats. Biochem. J. 235: 329-336, 1986[ISI][Medline].

34.   Jurasinski, C. V., and T. C. Vary. Insulin-like growth factor I accelerates protein synthesis in skeletal muscle during sepsis. Am. J. Physiol. Endocrinol. Metab. 269: E977-E981, 1995[Abstract/Free Full Text].

35.   Kimball, S. R., L. S. Jefferson, P. Fadden, T. A. Haystead, and J. C. Lawrence, Jr. Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle. Am. J. Physiol. Cell Physiol. 270: C705-C709, 1996[Abstract/Free Full Text].

36.   Kimball, S. R., T. C. Vary, and L. S. Jefferson. Regulation of protein synthesis by insulin. Annu. Rev. Physiol. 56: 321-348, 1994[ISI][Medline].

37.   Koziris, L. P., R. C. Hickson, R. T. Chatterton, R. T. Groseth, J. M. Christie, D. G. Goldflies, and T. G. Unterman. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J. Appl. Physiol. 86: 1436-1442, 1999[Abstract/Free Full Text].

38.   Lang, C. H., J. Fan, R. Cooney, and T. C. Vary. Interleukin-1 receptor antagonist attenuates sepsis-induced alterations in the insulin-like growth factor system and protein synthesis. Am. J. Physiol. Endocrinol. Metab. 270: E430-E437, 1996[Abstract/Free Full Text].

39.   Li, Y. H., J. Fan, and C. H. Lang. Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBP-I. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 272: R1990-R1997, 1997[Abstract/Free Full Text].

40.   McCusker, R. H., and D. R. Clemmons. The insulin-like growth factor binding proteins: structure and biological functions. In: The Insulin-Like Growth Factors: Structure and Biological Functions, edited by P. N. Schofielf. New York: Oxford University Press, 1992, p. 110-150.

41.   McNulty, P. H., L. H. Young, and E. J. Barrett. Response of rat heart and skeletal muscle protein in vivo to insulin and amino acid infusion. Am. J. Physiol. Endocrinol. Metab. 264: E958-E965, 1993[Abstract/Free Full Text].

42.   McNurlan, M., P. P. Essén, A. Calder, S. Anderson, O. Ljungqvist, A. Sandgren, I. Grant, I. Tjäder, P. E. Ballmer, J. Wernerman, and P. J. Garlick. Response of protein synthesis in human skeletal muscle to insulin: an investigation with L-[3H]phenylalanine. Am. J. Physiol. Endocrinol. Metab. 267: E102-E108, 1994[Abstract/Free Full Text].

43.   Morgan, C. R., and A. Lazarow. Immunoassay of insulin: two antibody system. Plasma levels of normal, subdiabetic and diabetic rats. Diabetes 12: 115-126, 1963[ISI].

44.   Nguyen, U. N., F. Mougin, M. L. Simon-Rigaud, J. D. Rouillon, P. Marguet, and J. Regnard. Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes. J. Appl. Physiol. 78: 533-537, 1998.

45.   Pacy, P. J., K. S. Nair, C. Ford, and D. Halliday. Failure of insulin infusion to stimulate fractional muscle protein synthesis in type 1 diabetic patients: anabolic effect of insulin and decreased proteolysis. Diabetes 38: 618-624, 1989[Abstract].

46.   Pain, V. M., and P. J. Garlick. Effect of streptozotocin diabetes and insulin treatment on the rate of protein synthesis in tissues of the rat in vivo. J. Biol. Chem 249: 4510-4514, 1974[Abstract/Free Full Text].

47.   Rannels, S. R., D. E. Rannels, A. E. Pegg, and L. S. Jefferson. Glucocorticoid effects on peptide-chain initiation in skeletal muscle and heart. Am. J. Physiol. Endocrinol. Metab. 235: E134-E139, 1978[Free Full Text].

48.   Rennie, M. J., K. Smith, and P. W. Watt. Measurement of human tissue protein synthesis: an optimal approach. Am. J. Physiol. Endocrinol. Metab. 266: E298-E307, 1994[Abstract/Free Full Text].

49.   Steenbergh, P. H., E. Jansen, F. M. A. van Schiak, and J. S. Sussenbach. Functional analysis of the human IGF-I gene promoters. Mol. Reprod. Dev. 35: 365-367, 1993[Medline].

50.   Tomas, F. M., S. E. Knowles, P. C. Owens, L. C. Read, C. S. Chandler, S. E. Gargosky, and F. J. Ballard. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I. Biochem. J. 276: 547-554, 1991.

51.   Vary, T. C., D. Dardevet, J. Grizard, L. Voisin, C. Buffiere, P. Denis, D. Breuille, and C. Obled. Differential regulation of skeletal muscle protein synthesis turnover by insulin and IGF-I after bacteremia. Am. J. Physiol. Endocrinol. Metab. 275: E584-E593, 1998[Abstract/Free Full Text].

52.   Wojnar, M. M., J. Fan, Y. H. Li, and C. H. Lang. Endotoxin-induced changes in IGF-I differ in rats provided enteral vs. parenteral nutrition. Am. J. Physiol. Endocrinol. Metab. 276: E455-E464, 1999[Abstract/Free Full Text].

53.   Wong, T. S., and F. W. Booth. Protein metabolism in rat gastrocnemius muscle after stimulated chronic concentric exercise. J. Appl. Physiol. 69: 1709-1717, 1990[Abstract/Free Full Text].

54.   Wong, T. S., and F. W. Booth. Protein metabolism in rat tibialis anterior muscle after stimulated chronic eccentric exercise. J. Appl. Physiol. 69: 1718-1724, 1990[Abstract/Free Full Text].

55.   Wray-Cahen, D., H. V. Nguyen, D. G. Burrin, P. R. Beckett, M. L. Fiorotto, P. J. Reeds, T. J. Wester, and T. A. Davis. Response of skeletal muscle protein synthesis to insulin in suckling pigs decreases with development. Am. J. Physiol. Endocrinol. Metab. 275: E602-E609, 1998[Abstract/Free Full Text].

56.   Yan, Z., R. Biggs, and F. Booth. Insulin-like growth factor immunoreactivity increases in muscle after acute eccentric exercise. J. Appl. Physiol. 74: 410-414, 1993[Abstract/Free Full Text].

57.   Yang, S., M. Alnaqeeb, H. Simpson, and G. Goldspink. Cloning and characterization of an IGF-I isoform expressed in skeletal muscle subjected to stretch. J. Muscle Res. Cell Motil. 17: 487-495, 1996[ISI][Medline].

58.   Young, L. H., W. Stirewalt, P. H. McNulty, J. H. Revkin, and E. J. Barrett. Effect of insulin on rat heart and skeletal muscle phenylalanyl-tRNA labeling and protein synthesis in vivo. Am. J. Physiol. Endocrinol. Metab. 267: E337-E342, 1994[Abstract/Free Full Text].


J APPL PHYSIOL 88(1):102-108
8570-7587/0 $5.00 Copyright © 2000 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
P. J. Morrison, D. Hara, Z. Ding, and J. L. Ivy
Adding protein to a carbohydrate supplement provided after endurance exercise enhances 4E-BP1 and RPS6 signaling in skeletal muscle
J Appl Physiol, April 1, 2008; 104(4): 1029 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. M. Lehti, M. Silvennoinen, R. Kivela, H. Kainulainen, and J. Komulainen
Effects of streptozotocin-induced diabetes and physical training on gene expression of titin-based stretch-sensing complexes in mouse striated muscle
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E533 - E542.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. M. Lehti, M. Silvennoinen, R. Kivela, H. Kainulainen, and J. Komulainen
Effects of streptozotocin-induced diabetes and physical training on gene expression of extracellular matrix proteins in mouse skeletal muscle
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E900 - E907.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Prod'homme, C. Rochon, M. Balage, H. Laurichesse, I. Tauveron, C. Champredon, P. Thieblot, J. Beytout, and J. Grizard
Whole body leucine flux in HIV-infected patients treated with or without protease inhibitors
Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E685 - E693.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Kubica, D. R. Bolster, P. A. Farrell, S. R. Kimball, and L. S. Jefferson
Resistance Exercise Increases Muscle Protein Synthesis and Translation of Eukaryotic Initiation Factor 2B{epsilon} mRNA in a Mammalian Target of Rapamycin-dependent Manner
J. Biol. Chem., March 4, 2005; 280(9): 7570 - 7580.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Prod'homme, M. Balage, E. Debras, M.-C. Farges, S. Kimball, L. Jefferson, and J. Grizard
Differential effects of insulin and dietary amino acids on muscle protein synthesis in adult and old rats
J. Physiol., February 15, 2005; 563(1): 235 - 248.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. D. Fluckey, E. E. Dupont-Versteegden, M. Knox, D. Gaddy, P. A. Tesch, and C. A. Peterson
Insulin facilitation of muscle protein synthesis following resistance exercise in hindlimb-suspended rats is independent of a rapamycin-sensitive pathway
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1070 - E1075.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. M. J. O'Connor, J. A. Bush, A. Suryawan, H. V. Nguyen, and T. A. Davis
Insulin and amino acids independently stimulate skeletal muscle protein synthesis in neonatal pigs
Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E110 - E119.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. R. Kimball, P. A. Farrell, and L. S. Jefferson
Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or exercise
J Appl Physiol, September 1, 2002; 93(3): 1168 - 1180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Balage, S. Sinaud, M. Prod'Homme, D. Dardevet, T. C. Vary, S. R. Kimball, L. S. Jefferson, and J. Grizard
Amino acids and insulin are both required to regulate assembly of the eIF4E {middle dot} eIF4G complex in rat skeletal muscle
Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E565 - E574.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. D. Tipton, B. B. Rasmussen, S. L. Miller, S. E. Wolf, S. K. Owens-Stovall, B. E. Petrini, and R. R. Wolfe
Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise
Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E197 - E206.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. C. Kostyak, S. R. Kimball, L. S. Jefferson, and P. A. Farrell
Severe diabetes inhibits resistance exercise-induced increase in eukaryotic initiation factor 2B activity
J Appl Physiol, July 1, 2001; 91(1): 79 - 84.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Fedele, C. H. Lang, and P. A. Farrell
Immunization against IGF-I prevents increases in protein synthesis in diabetic rats after resistance exercise
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E877 - E885.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Fedele, T. C. Vary, and P. A Farrell
Plasticity in Skeletal, Cardiac, and Smooth Muscle: Selected Contribution: IGF-I antibody prevents increases in protein synthesis in epitrochlearis muscles from refed, diabetic rats
J Appl Physiol, March 1, 2001; 90(3): 1166 - 1173.
[Abstract] [Full Text] [PDF]